CN107164304A - A kind of method of convenient cell recovery - Google Patents

A kind of method of convenient cell recovery Download PDF

Info

Publication number
CN107164304A
CN107164304A CN201710527043.9A CN201710527043A CN107164304A CN 107164304 A CN107164304 A CN 107164304A CN 201710527043 A CN201710527043 A CN 201710527043A CN 107164304 A CN107164304 A CN 107164304A
Authority
CN
China
Prior art keywords
parts
cell recovery
basal medium
cell
convenient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710527043.9A
Other languages
Chinese (zh)
Inventor
王文峰
曹先艳
马莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dong Xun Bio Tech Ltd Granary
Original Assignee
Dong Xun Bio Tech Ltd Granary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Xun Bio Tech Ltd Granary filed Critical Dong Xun Bio Tech Ltd Granary
Priority to CN201710527043.9A priority Critical patent/CN107164304A/en
Publication of CN107164304A publication Critical patent/CN107164304A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/35Polyols, e.g. glycerin, inositol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2302Interleukin-2 (IL-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2304Interleukin-4 (IL-4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2314Interleukin-14 (IL-14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/24Interferons [IFN]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere

Abstract

The invention provides a kind of method of convenient cell recovery, comprise the following steps:The cell cryopreservation tube frozen is taken out from liquid nitrogen or 80 DEG C of refrigerators, rock to the cell liquid containing cells frozen storing liquid and melt completely in 37 DEG C in 1min after taking-up, cell liquid is even added in the Tissue Culture Dish for filling 7 9ml fresh cultures, rock clockwise under Tissue Culture Dish 35, in 37 DEG C, 5%CO2Cultivated in incubator.The method of convenient cell recovery of the present invention, its method rationally, using convenient, can be rapidly used for biological and healthy correlative study.

Description

A kind of method of convenient cell recovery
Technical field
The invention belongs to biological technology application, in particular it relates to a kind of method of convenient cell recovery.
Background technology
Cell culture is a biological important technology with healthy Related Research Domain.With the rapid hair of life science Exhibition, current cell culture turns into the important base of the disciplinary studies such as cell biology, molecular biology, science of heredity and immunology Plinth.In order to further investigated cell vegetative activity rule, have the pathology of related disorders and the pharmacology of medicine(Toxicity)Mechanism, exploitation tool There are different targetedly cell culture processes significant.
Cell recovery is the one kind for cultivating cell, is wide variety of key technology in life and regenerative medicine field, Generally require to recover to the cell frozen in research.Especially as the rise of cell therapy personalization technology, amplification in vitro The cell of special efficacy is into preclinical study and the emphasis development project of clinical treatment.With amplification in vitro special efficacy Cell is included by multi-functional candidate stem cell, T cell, NK cells, DC cells and CIK cell etc., by this kind of cells in vitro Fed back to again in lactation organism after amplification, be conducive to improving the hematopoietic device function of body:Such as lift red blood cell, be immunized carefully The maintenance of quantity and function, anti-tumor capacity and the immune defense ability of born of the same parents etc..
The content of the invention
Goal of the invention:It is thin for a variety of people sources and inhuman source the invention provides a kind of method of convenient cell recovery The recovery of born of the same parents.
Technical scheme:The invention provides a kind of method of convenient cell recovery, comprise the following steps:By the cell frozen Cryopreservation tube takes out from liquid nitrogen or -80 DEG C of refrigerators, is rocked after taking-up in 1min in 37 DEG C to containing the thin of cells frozen storing liquid Cytosol melts completely, cell liquid is even added in the Tissue Culture Dish for filling 7-9ml fresh cultures, rocks thin clockwise Under born of the same parents' culture dish 3-5, in 37 DEG C, 5%CO2Cultivated in incubator.The method of convenient cell recovery of the present invention, its method Rationally, using convenient, biological and healthy correlative study can be rapidly used for.
Further, the method for above-mentioned convenient cell recovery, the basal medium of the culture medium including 70-90% with And 10-30% hyclone.Nutrient media components is rationally, nutritious, and more nutrients can be provided for cell culture(Bag Include growth factor etc.), high cell growth speed, cell state is good.
Further, the method for above-mentioned convenient cell recovery, the cells frozen storing liquid is by weight part, including following Component:5-15 parts of dimethyl sulfoxide (DMSO), 2-5 parts of HES, 5-10 parts of chitosan, 2-5 parts of glutathione, vitamin C 1-4 Part, 0.3-4 parts of dextran, 0.5-2 parts of propane diols, N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiazole carboxamides 0.1-1 80-90 parts of part and basal medium.Frozen stock solution component is rationally, nutritious, and wherein dextran is permeability protection liquid, and N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiazole carboxamides then suppress cellular activity and gene expression, ascorbic anti-oxidant Property it is good, can also substantially reduce the damage to cell while the nutrition of rest cell is ensured, improve the survival of freeze-stored cell Rate, and also keep in terms of propagation good state.
Further, the method for above-mentioned convenient cell recovery, the basal medium is by weight part, including following Component:80-90 parts of glucose, 10-20 parts of sodium acid carbonate, 8-18 parts of Sodium Pyruvate, 3-12 parts of sericin, potassium chloride 30- 50 parts, 5-12 parts of anhydrous magnesium sulfate, 60-80 parts of sodium chloride, 8-16 parts of AMSP, 0.2-0.6 parts of folic acid, flesh 0.5-1.5 parts of alcohol, 0.2-0.8 parts of niacinamide, 20-40 parts of anhydrous calcium chloride, 0.1-0.5 parts of ferric nitrate, 5-10 parts of succinic acid, 9-18 parts of sodium succinate, 0.2-0.8 parts of D-VB5 calcium, 0.5-1 parts of choline tartrate, 0.1-0.3 parts of riboflavin, thiamine hydrochloride 0.1-0.5 parts, 0.1-0.6 parts of pyridoxine hydrochloride, 0.1-0.5 parts of NIPA, 0.3-3 parts of leukotrienes, monoethanolamine 0.5-0.8 parts, 0.2-0.9 parts of aromatic esters, phenol red sodium 0.8-1.5 parts and 100 parts of deionized water.
Further, the method for above-mentioned convenient cell recovery, the basal medium also includes 3-8 parts of amino acid, institute State amino acid by weight part, it is composed of the following components:5-10 parts of L- R-genes, 3-8 parts of L- hydrochloric acid cystines, L- 3-6 parts of serine, 1-5 parts of glycine, 4-6 parts of L- histidine monohydrochlorides, 8-20 parts of ILE, 7-18 parts of L-Leu, L- 10-20 parts of lysine hydrochloride, 1-6 parts of METHIONINE, 2-8 parts of L-phenylalanine, 5-15 parts of L-threonine, L-Trp 1-3 8-12 parts of part, 5-9 parts of TYR and Valine.
Further, the method for above-mentioned convenient cell recovery, the basal medium also includes 2-5 parts of confactors, The confactor is by weight part, composed of the following components:It is 2-10 parts of recombination human basic fibroblast growth factor, white 1-4 parts of 3-8 parts of interleukin 2,3-6 parts of IL-4,1-5 parts of interleukin-11 4,3-6 parts of IFN-γ and neuroleukin.
Further, the method for above-mentioned convenient cell recovery, the basal medium by weight part, in addition to 0.006 part of penicillin and 0.01 part of streptomysin.The cell of recovery can be effectively prevented to be contaminated.
Further, the method for above-mentioned convenient cell recovery, the penicillin is selected from 10000U/ml, the streptomysin Selected from 10000 μ g/ml.Penicillin and streptomysin activity are good, and effect is good.
Further, the method for above-mentioned convenient cell recovery, the Tissue Culture Dish is 10cm Tissue Culture Dish.
Beneficial effect:The method of convenient cell recovery of the present invention, its method rationally, can be notable using convenient The damage frozen to cell is reduced, the cell survival rate high state after recovery is good, cell boundaries are clear, high cell growth speed, Biological and healthy correlative study can be rapidly used for.
Embodiment
Below will be by several specific embodiments, the present invention is furture elucidated, these embodiments simply to illustrate that problem, It is not a kind of limitation.
Embodiment 1
A kind of method of convenient cell recovery, comprises the following steps:By the cell cryopreservation tube frozen from liquid nitrogen or -80 DEG C of refrigerators It is middle to take out, rock to the cell liquid containing cells frozen storing liquid and melt completely in 37 DEG C in 1min after taking-up, cell liquid is uniform It is added in the 10cm Tissue Culture Dish for filling 7ml fresh cultures, rocks clockwise under Tissue Culture Dish 3, in 37 DEG C, 5% CO2Cultivated in incubator.
Wherein, the culture medium includes 70% basal medium and 30% hyclone.In addition, the cells frozen storing liquid By weight part, including following components:5 parts of dimethyl sulfoxide (DMSO), 2 parts of HES, 5 parts of chitosan, 2 parts of glutathione, 1 part of vitamin C, 0.3 part of dextran, 0.5 part of propane diols, N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiazole carboxamides 0.1 part and 80 parts of basal medium.
Further, the method for above-mentioned convenient cell recovery, the basal medium is by weight part, including following Component:80 parts of glucose, 10 parts of sodium acid carbonate, 8 parts of Sodium Pyruvate, 3 parts of sericin, 30 parts of potassium chloride, anhydrous magnesium sulfate 5 parts, 60 parts of sodium chloride, 8 parts of AMSP, 0.2 part of folic acid, 0.5 part of inositol, 0.2 part of niacinamide, anhydrous calcium chloride 20 parts, 0.1 part of ferric nitrate, 5 parts of succinic acid, 9 parts of sodium succinate, 0.2 part of D-VB5 calcium, 0.5 part of choline tartrate, riboflavin 0.1 part, 0.1 part of thiamine hydrochloride, 0.1 part of pyridoxine hydrochloride, 0.1 part of NIPA, 0.3 part of leukotrienes, monoethanolamine 100 parts of 0.5 part, 0.2 part of aromatic esters, 0.8 part of phenol red sodium and deionized water.
In addition, the basal medium also includes 3 parts of amino acid, the amino acid by weight part, by following components group Into:5 parts of L- R-genes, 3 parts of L- hydrochloric acid cystine, 3 parts of Serine, 1 part of glycine, 4 parts of L- histidine monohydrochlorides, 8 parts of ILE, 7 parts of L-Leu, 10 parts of LYS, 1 part of METHIONINE, 2 parts of L-phenylalanine, L- Soviet Unions ammonia 8 parts of 5 parts of acid, 1 part of L-Trp, 5 parts of TYR and Valine.
Again, the basal medium also includes 2 parts of confactors, the confactor by weight part, by with the following group It is grouped into:2 parts of recombination human basic fibroblast growth factor, 3 parts of interleukin-22,3 parts of IL-4,41 parts of interleukin-11, 1 part of 3 parts of IFN-γ and neuroleukin.
In addition, the basal medium is by weight part, in addition to 0.006 part of penicillin and 0.01 part of streptomysin. Also, the penicillin is selected from 10000U/ml, the streptomysin is selected from 10000 μ g/ml.
Embodiment 2
A kind of method of convenient cell recovery, comprises the following steps:By the cell cryopreservation tube frozen from liquid nitrogen or -80 DEG C of refrigerators It is middle to take out, rock to the cell liquid containing cells frozen storing liquid and melt completely in 37 DEG C in 1min after taking-up, cell liquid is uniform It is added in the 10cm Tissue Culture Dish for filling 9ml fresh cultures, rocks clockwise under Tissue Culture Dish 5, in 37 DEG C, 5% CO2Cultivated in incubator.
Wherein, the culture medium includes 90% basal medium and 10% hyclone.In addition, the cells frozen storing liquid By weight part, including following components:15 parts of dimethyl sulfoxide (DMSO), 5 parts of HES, 10 parts of chitosan, glutathione 5 Part, 4 parts of vitamin C, 4 parts of dextran, 2 parts of propane diols, N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiazole carboxamides 1 90 parts of part and basal medium.
Further, the method for above-mentioned convenient cell recovery, 90 parts of glucose, 20 parts of sodium acid carbonate, Sodium Pyruvate 18 Part, 12 parts of sericin, 50 parts of potassium chloride, 12 parts of anhydrous magnesium sulfate, 80 parts of sodium chloride, 16 parts of AMSP, folic acid 0.6 part, 1.5 parts of inositol, 0.8 part of niacinamide, 40 parts of anhydrous calcium chloride, 0.5 part of ferric nitrate, 10 parts of succinic acid, sodium succinate 18 Part, 0.8 part of D-VB5 calcium, 1 part of choline tartrate, 0.3 part of riboflavin, 0.5 part of thiamine hydrochloride, 0.6 part of pyridoxine hydrochloride, N- 0.5 part of N-isopropylacrylamide, 3 parts of leukotrienes, 0.8 part of monoethanolamine, 0.9 part of aromatic esters, 1.5 parts of phenol red sodium and deionized water 100 parts.
In addition, the basal medium also includes 8 parts of amino acid, the amino acid by weight part, by following components group Into:10 parts of L- R-genes, 8 parts of L- hydrochloric acid cystine, 6 parts of Serine, 5 parts of glycine, 6 parts of L- histidine monohydrochlorides, 20 parts of ILE, 18 parts of L-Leu, 20 parts of LYS, 6 parts of METHIONINE, 8 parts of L-phenylalanine, L- Soviet Unions 12 parts of 15 parts of propylhomoserin, 3 parts of L-Trp, 9 parts of TYR and Valine.
Again, the basal medium also includes 5 parts of confactors, the confactor by weight part, by with the following group It is grouped into:10 parts of recombination human basic fibroblast growth factor, 8 parts of interleukin-22,6 parts of IL-4,45 parts of interleukin-11, 4 parts of 6 parts of IFN-γ and neuroleukin.
In addition, the basal medium is by weight part, in addition to 0.006 part of penicillin and 0.01 part of streptomysin. Also, the penicillin is selected from 10000U/ml, the streptomysin is selected from 10000 μ g/ml.
Embodiment 3
A kind of method of convenient cell recovery, comprises the following steps:By the cell cryopreservation tube frozen from liquid nitrogen or -80 DEG C of refrigerators It is middle to take out, rock to the cell liquid containing cells frozen storing liquid and melt completely in 37 DEG C in 1min after taking-up, cell liquid is uniform It is added in the 10cm Tissue Culture Dish for filling 8ml fresh cultures, rocks clockwise under Tissue Culture Dish 4, in 37 DEG C, 5% CO2Cultivated in incubator.
Wherein, the culture medium includes 80% basal medium and 20% hyclone.In addition, the cells frozen storing liquid By weight part, including following components:10 parts of dimethyl sulfoxide (DMSO), 3 parts of HES, 6 parts of chitosan, 3 parts of glutathione, Catergen part, 3 parts of dextran, 1 part of propane diols, 0.8 part of N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiazole carboxamides With 85 parts of basal medium.
Further, the method for above-mentioned convenient cell recovery, the basal medium is by weight part, including following Component:86 parts of glucose, 18 parts of sodium acid carbonate, 12 parts of Sodium Pyruvate, 6 parts of sericin, 40 parts of potassium chloride, anhydrous magnesium sulfate 8 Part, 75 parts of sodium chloride, 12 parts of AMSP, 0.4 part of folic acid, 1 part of inositol, 0.5 part of niacinamide, anhydrous calcium chloride 30 Part, 0.3 part of ferric nitrate, 7 parts of succinic acid, 14 parts of sodium succinate, 0.5 part of D-VB5 calcium, 0.7 part of choline tartrate, riboflavin 0.2 part, 0.3 part of thiamine hydrochloride, 0.4 part of pyridoxine hydrochloride, 0.3 part of NIPA, 1.6 parts of leukotrienes, monoethanolamine 100 parts of 0.7 part, 0.5 part of aromatic esters, 1.2 parts of phenol red sodium and deionized water.
In addition, the basal medium also includes 6 parts of amino acid, the amino acid by weight part, by following components group Into:8 parts of L- R-genes, 6 parts of L- hydrochloric acid cystine, 5 parts of Serine, 3 parts of glycine, 5 parts of L- histidine monohydrochlorides, 12 parts of ILE, 10 parts of L-Leu, 15 parts of LYS, 3 parts of METHIONINE, 4 parts of L-phenylalanine, L- Soviet Unions 9 parts of 9 parts of propylhomoserin, 2 parts of L-Trp, 6 parts of TYR and Valine.
Again, the basal medium also includes 3 parts of confactors, the confactor by weight part, by with the following group It is grouped into:6 parts of recombination human basic fibroblast growth factor, 5 parts of interleukin-22,4 parts of IL-4,45 parts of interleukin-11, 3 parts of 5 parts of IFN-γ and neuroleukin.
In addition, the basal medium is by weight part, in addition to 0.006 part of penicillin and 0.01 part of streptomysin. Also, the penicillin is selected from 10000U/ml, the streptomysin is selected from 10000 μ g/ml.
Embodiment 4
A kind of method of convenient cell recovery, comprises the following steps:By the cell cryopreservation tube frozen from liquid nitrogen or -80 DEG C of refrigerators It is middle to take out, rock to the cell liquid containing cells frozen storing liquid and melt completely in 37 DEG C in 1min after taking-up, cell liquid is uniform It is added in the 10cm Tissue Culture Dish for filling 9ml fresh cultures, rocks clockwise under Tissue Culture Dish 5, in 37 DEG C, 5% CO2Cultivated in incubator.
Wherein, the culture medium includes 70 basal medium and 30% hyclone.In addition, the cells frozen storing liquid By weight part, including following components:15 parts of dimethyl sulfoxide (DMSO), 2 parts of HES, 6 parts of chitosan, 3 parts of glutathione, 1 part of vitamin C, 4 parts of dextran, 1 part of propane diols, 0.8 part of N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiazole carboxamides With 90 parts of basal medium.
Further, the method for above-mentioned convenient cell recovery, the basal medium is by weight part, including following Component:82 parts of glucose, 25 parts of sodium acid carbonate, 12 parts of Sodium Pyruvate, 6 parts of sericin, 45 parts of potassium chloride, anhydrous magnesium sulfate 6 parts, 72 parts of sodium chloride, 14 parts of AMSP, 0.3 part of folic acid, 1 part of inositol, 0.3 part of niacinamide, anhydrous calcium chloride 35 Part, 0.3 part of ferric nitrate, 6 parts of succinic acid, 12 parts of sodium succinate, 0.6 part of D-VB5 calcium, 0.7 part of choline tartrate, riboflavin 0.2 part, 0.3 part of thiamine hydrochloride, 0.4 part of pyridoxine hydrochloride, 0.4 part of NIPA, 2 parts of leukotrienes, monoethanolamine 100 parts of 0.6 part, 0.3 part of aromatic esters, 1.3 parts of phenol red sodium and deionized water.
In addition, the basal medium also includes 7 parts of amino acid, the amino acid by weight part, by following components group Into:5 parts of L- R-genes, 8 parts of L- hydrochloric acid cystine, 6 parts of Serine, 3 parts of glycine, 5 parts of L- histidine monohydrochlorides, 12 parts of ILE, 18 parts of L-Leu, 10 parts of LYS, 5 parts of METHIONINE, 4 parts of L-phenylalanine, L- Soviet Unions 8 parts of 10 parts of propylhomoserin, 3 parts of L-Trp, 5 parts of TYR and Valine.
Again, the basal medium also includes 3 parts of confactors, the confactor by weight part, by with the following group It is grouped into:2 parts of recombination human basic fibroblast growth factor, 8 parts of interleukin-22,3 parts of IL-4,44 parts of interleukin-11, 2 parts of 5 parts of IFN-γ and neuroleukin.
In addition, the basal medium is by weight part, in addition to 0.006 part of penicillin and 0.01 part of streptomysin. Also, the penicillin is selected from 10000U/ml, the streptomysin is selected from 10000 μ g/ml.
Described above is only several embodiments of invention, it is noted that for those skilled in the art For, on the premise of inventive principle is not departed from, some improvement can also be made, these improvement also should be regarded as the protection of the present invention Scope.

Claims (9)

1. a kind of method of convenient cell recovery, it is characterised in that:Comprise the following steps:By the cell cryopreservation tube frozen from liquid nitrogen Or taken out in -80 DEG C of refrigerators, rock to the cell liquid containing cells frozen storing liquid and melt completely in 37 DEG C in 1min after taking-up, Cell liquid is even added in the Tissue Culture Dish for filling 7-9ml fresh cultures, Tissue Culture Dish 3-5 is rocked clockwise Under, in 37 DEG C, 5%CO2Cultivated in incubator.
2. the method for convenient cell recovery according to claim 1, it is characterised in that:The culture medium includes 70-90%'s The hyclone of basal medium and 10-30%.
3. the method for convenient cell recovery according to claim 1, it is characterised in that:The cells frozen storing liquid is with weight group Divide meter, including following components:5-15 parts of dimethyl sulfoxide (DMSO), 2-5 parts of HES, 5-10 parts of chitosan, glutathione 2-5 Part, 1-4 parts of vitamin C, 0.3-4 parts of dextran, 0.5-2 parts of propane diols, N- (benzyl) -2- (4- pyrimdinyl-aminos) -4- thiophenes 80-90 parts of 0.1-1 parts of azoles formamide and basal medium.
4. the method for the convenient cell recovery according to Claims 2 or 3, it is characterised in that:The basal medium is with weight Measure component meter, including following components:80-90 parts of glucose, 10-20 parts of sodium acid carbonate, 8-18 parts of Sodium Pyruvate, sericin 3-12 parts, 30-50 parts of potassium chloride, 5-12 parts of anhydrous magnesium sulfate, 60-80 parts of sodium chloride, 8-16 parts of AMSP, 0.2-0.6 parts of folic acid, 0.5-1.5 parts of inositol, 0.2-0.8 parts of niacinamide, 20-40 parts of anhydrous calcium chloride, ferric nitrate 0.1-0.5 Part, 5-10 parts of succinic acid, 9-18 parts of sodium succinate, 0.2-0.8 parts of D-VB5 calcium, 0.5-1 parts of choline tartrate, riboflavin 0.1-0.3 parts, it is 0.1-0.5 parts of thiamine hydrochloride, 0.1-0.6 parts of pyridoxine hydrochloride, 0.1-0.5 parts of NIPA, sub- Numb 0.3-3 parts of acid, 0.5-0.8 parts of monoethanolamine, 0.2-0.9 parts of aromatic esters, phenol red sodium 0.8-1.5 parts and 100 parts of deionized water.
5. the method for convenient cell recovery according to claim 4, it is characterised in that:The basal medium also includes 3- 8 parts of amino acid, the amino acid is by weight part, composed of the following components:5-10 parts of L- R-genes, L- hydrochloric acid Guangs 3-8 parts of propylhomoserin, 3-6 parts of Serine, 1-5 parts of glycine, 4-6 parts of L- histidine monohydrochlorides, 8-20 parts of ILE, L- are bright 7-18 parts of propylhomoserin, 10-20 parts of LYS, 1-6 parts of METHIONINE, 2-8 parts of L-phenylalanine, L-threonine 5-15 Part, 1-3 parts of L-Trp, 5-9 parts of TYR and 8-12 parts of Valine.
6. the method for convenient cell recovery according to claim 5, it is characterised in that:The basal medium also includes 2- 5 parts of confactors, the confactor is by weight part, composed of the following components:Recombination human basic fibroblast growth 2-10 parts of the factor, 3-8 parts of interleukin-22,3-6 parts of IL-4,1-5 parts of interleukin-11 4,3-6 parts of IFN-γ and neural leucocyte It is plain 1-4 parts.
7. the method for convenient cell recovery according to claim 6, it is characterised in that:The basal medium is with weight group Divide meter, in addition to 0.006 part of penicillin and 0.01 part of streptomysin.
8. the method for convenient cell recovery according to claim 7, it is characterised in that:The penicillin is selected from 10000U/ Ml, the streptomysin is selected from 10000 μ g/ml.
9. the method for convenient cell recovery according to claim 1, it is characterised in that:The Tissue Culture Dish is that 10cm is thin Born of the same parents' culture dish.
CN201710527043.9A 2017-06-30 2017-06-30 A kind of method of convenient cell recovery Pending CN107164304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710527043.9A CN107164304A (en) 2017-06-30 2017-06-30 A kind of method of convenient cell recovery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710527043.9A CN107164304A (en) 2017-06-30 2017-06-30 A kind of method of convenient cell recovery

Publications (1)

Publication Number Publication Date
CN107164304A true CN107164304A (en) 2017-09-15

Family

ID=59827735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710527043.9A Pending CN107164304A (en) 2017-06-30 2017-06-30 A kind of method of convenient cell recovery

Country Status (1)

Country Link
CN (1) CN107164304A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1698690A1 (en) * 2003-12-26 2006-09-06 Makoto Asashima Basal medium for es cell culturing
CN102305747A (en) * 2011-05-27 2012-01-04 苏州大学 Biomarker reagent used for detecting breast cancer state

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1698690A1 (en) * 2003-12-26 2006-09-06 Makoto Asashima Basal medium for es cell culturing
CN102305747A (en) * 2011-05-27 2012-01-04 苏州大学 Biomarker reagent used for detecting breast cancer state

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
PHYSICAL SCIENCES-ONCOLOGY CENTER NETWORK BIORESOURCE CORE FACIL: "Protocal for thawing,propagation and cryopreservation of NCl-PBCF-HTB26(MDA-MB-231)(ATCC HTB-26TM) breast adenocarcinoma", 《AMERCIAN TYPE CULTURE COLLECTION》 *
储炬: "《现代生物工艺学》", 30 September 2007 *
刘冬: "《食品生物技术》", 30 June 2008 *
无: "DMEM细胞培养基的成分", 《HTTP://WWW.BIOMART.CN/EXPERIMENT/430/488/489/37921.HTM》 *
陈宁: "《酶工程》", 30 June 2011, 中国轻工业出版社 *

Similar Documents

Publication Publication Date Title
CN107156108A (en) A kind of peripheral hematopoietic stem cells preserve liquid and preparation method
CN104560869B (en) A kind of method for preparing chorion mescenchymal stem cell
CN107926933A (en) A kind of cell-preservation liquid
CA2549564A1 (en) Tissue preservation media
CN107094752A (en) A kind of tumor tissues storage in vitro liquid and preparation method thereof
CN106256203B (en) A kind of stem cell cryopreserving system and its application method
CN104222069A (en) Erythroid progenitor cell cryopreservation liquid and application thereof
CN108085303A (en) Optimization method and its application in cosmetics prepared by a kind of active Cordyceps sinensis ferment
CN103421740B (en) In-vitro culture and proliferation method for human mesenchymal stem cells
CN106520679A (en) Kit for culturing pancreas stem cells
CN107164304A (en) A kind of method of convenient cell recovery
KR101668743B1 (en) A composition for preserving cells comprising plant-derived recombinant human serum albumin and plant peptide
CN107217031A (en) A kind of cell recovery method of high viability
CN113994951A (en) CIK cell cryopreservation liquid and cryopreservation method
CN107251894A (en) A kind of cell freezing method of high viability
US20210289770A1 (en) Compositions for transportation and/or cryopreservation of cells and/or tissues
CN100519742C (en) Ultra-low temperature preservation solution for animal cells and preserving method
Minami et al. Creatine kinase and troponin after myocardial preservation using HTK solution (Custoidol) for clinical heart transplantation
CN107217027A (en) A kind of method of high nutrition cell expansion culture
CN107217030A (en) A kind of wide spectrum cell culture medium
CN108096186A (en) A kind of liver stem cells parenteral solution and preparation method thereof
KR20110016175A (en) Method and composition for preserving cells
Vielkind et al. DNA-mediated transformation in the platyfish-swordtail melanoma system
US20220195393A1 (en) Methods for storage of stem cells
CN107164311A (en) A kind of convenient, quick Vero cells method for resuscitation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170915